The activation, clonal expansion and terminal differentiation of small resting B lymphocytes primed by an antigen (or antibodies to its receptors) appear to follow an orderly developmental sequence triggered at each stage by distinct soluble cytokines, primarily produced by T lymphocytes1,2. For man, the only known B-cell mitogen independent of accessory cells for its action is the Epstein–Barr virus (EBV). Lymphocytes transformed by EBV are released from the usual constraints on B-cell growth, proliferating continuously in the absence of any exogenous cytokine3. The resultant cell lines are of special interest as they possess certain features compatible with a preneoplastic state of Burkitt's lymphoma, one of two human cancers with which the virus is intimately associated3. We report here that following EBV-transformation, B lympho-blasts release a soluble factor which mimics the B-cell stimulatory product(s) of mitogen-conditioned T lymphocytes. Furthermore, the virally-transformed cells utilize this activity to sustain their own growth. The ectopic production of an otherwise normal growth factor may represent a critical event in the malignant evolution of human lymphomas harbouring the EBV genome.
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Andersson, J. & Melchers, F. Proc. natn. Acad. Sci. U.S.A. 78, 2479–2501 (1981).
Howard, M. & Paul, W. E. A. Rev. Immun. 1, 307–333 (1983).
Nilsson, K. & Klein, G. Adv. Cancer Res. 37, 319–380 (1982).
Maruguchi, A., Butler, J. L., Kehrl, J. H. & Fauci, A. S. J. exp. Med. 157, 530–546 (1983).
Gordon, J., Ley, S. C., Melamed, M. D., Aman, P. & Hughes-Jones, N. C. J. exp. Med. 159, 1554–1559 (1984).
Blazar, B. A., Sutton, L. M. & Strome, M. Cancer Res. 43, 4562–4569 (1983).
Maizel, A. et al. Proc. natn. Acad. Sci. U.S.A. 79, 5998–6002 (1982).
Uittenbogaart, C. H. & Fahey, J. L. Proc. natn. Acad. Sci. U.S.A. 79, 7004–7008 (1982).
Twardzik, D. R. et al. Science 216, 894–897 (1982).
Kaplan, P. L., Anderson, M. & Ozanne, B. Proc. natn. Acad. Sci. U.S.A. 79, 485–489 (1982).
Anzano, M. A. et al. Proc. natn. Acad. Sci. U.S.A. 80, 6204–6268 (1983).
Robbins, K. C. et al. Nature 305, 605–608 (1983).
Waterfield, M. C. et al. Nature 304, 35–39 (1983).
Downward, J et al. Nature 307, 521–527 (1984).
Brickell, P. M. et al. Nature 306, 756–760 (1983).
Bernards, R. et al. Nature 305, 776–779 (1983).
Klein, G. Cell 32, 311–315 (1983).
Perry, R. P. Cell 33, 647–649 (1983).
Rabbits, T. H., Hamlyn, P. H. & Baer, R. Nature 306, 760–765 (1983).
Gordon, J., Melamed, M. D., Ley, S. C. & Hughes-Jones, N. C. Immunology 52, 79–85 (1984).
About this article
Cite this article
Gordon, J., Ley, S., Melamed, M. et al. Immortalized B lymphocytes produce B-cell growth factor. Nature 310, 145–147 (1984). https://doi.org/10.1038/310145a0
Current Sports Medicine Reports (2020)
Cell Proliferation (2008)
Annals of the New York Academy of Sciences (2008)
Induction of B cell responsiveness to growth factors by Epstein-Barr virus conversion: comparison of endogenous factors and interleukin-1
Clinical & Experimental Immunology (2008)
Maintenance of the CD40-related immunodeficient response in hyper-IgM B cells immortalized with a LMP1-regulated mini-EBV
Journal of Leukocyte Biology (2005)